找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Metallic Nanostructures; From Controlled Synt Yujie Xiong,Xianmao Lu Book 2015 Springer International Publishing Switzerland 2015 Bimetalli

[復制鏈接]
樓主: Dopamine
21#
發(fā)表于 2025-3-25 05:54:30 | 只看該作者
22#
發(fā)表于 2025-3-25 10:41:25 | 只看該作者
Zhenmeng Pengpeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
23#
發(fā)表于 2025-3-25 12:44:48 | 只看該作者
W. David Wei,Brendan C. Sweeny,Jingjing Qiu,Joseph S. DuChenepeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
24#
發(fā)表于 2025-3-25 16:23:36 | 只看該作者
Shan Zhou,Yujie Xiongpeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
25#
發(fā)表于 2025-3-25 21:59:34 | 只看該作者
26#
發(fā)表于 2025-3-26 03:46:38 | 只看該作者
Ran Long,Yujie Xionge. Relevant chemical modifications also include conjugated targeting ligands to assist ON delivery to specific cell types. Chemical modifications are most beneficial for therapeutically relevant ONs, as they serve to enhance target binding, increase drug longevity, facilitate cell-specific targeting
27#
發(fā)表于 2025-3-26 05:20:44 | 只看該作者
28#
發(fā)表于 2025-3-26 12:29:36 | 只看該作者
Yanglong Hou,Jing Yu,Wenlong Yangintracellular and extracellular barriers. The reader will gain an insight into RNA interference from the cellular mechanisms to screening to siRNA design right through to diagnostic and therapeutic applications.978-1-4899-9319-9978-1-4614-4744-3Series ISSN 2192-6204 Series E-ISSN 2192-6212
29#
發(fā)表于 2025-3-26 14:49:38 | 只看該作者
Zhenmeng Pengintracellular and extracellular barriers. The reader will gain an insight into RNA interference from the cellular mechanisms to screening to siRNA design right through to diagnostic and therapeutic applications.978-1-4899-9319-9978-1-4614-4744-3Series ISSN 2192-6204 Series E-ISSN 2192-6212
30#
發(fā)表于 2025-3-26 17:53:41 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-25 10:27
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
武穴市| 哈尔滨市| 枣强县| 吕梁市| 华宁县| 平原县| 克拉玛依市| 沛县| 亚东县| 思南县| 巴塘县| 鹤山市| 景泰县| 瑞丽市| 保康县| 临猗县| 扶沟县| 法库县| 临武县| 云和县| 古蔺县| 东港市| 临颍县| 蚌埠市| 盐源县| 古田县| 崇阳县| 建水县| 磐石市| 工布江达县| 津南区| 兴化市| 邹城市| 同德县| 东宁县| 越西县| 冕宁县| 岐山县| 博湖县| 陈巴尔虎旗| 天镇县|